| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sillevis Smitt JH and de Mari F | A serious side-effect of etretinate (Tigason). | 1984 | Clin. Exp. Dermatol. | pmid:6437712 |
| Lassus A | Re-PUVA. | 1984 | Photodermatol | pmid:6533618 |
| Foged E et al. | Histologic changes in the liver during etretinate treatment. | 1984 | J. Am. Acad. Dermatol. | pmid:6490982 |
| Schwarz T et al. | Disseminated superficial "actinic" porokeratosis. | 1984 | J. Am. Acad. Dermatol. | pmid:6490996 |
| Pearson LH et al. | Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet. | 1984 | J. Am. Acad. Dermatol. | pmid:6491002 |
| Baran R et al. | The nails in keratosis lichenoides chronica. Characteristics and response to treatment. | 1984 | Arch Dermatol | pmid:6497414 |
| Marcelo CL and Madison KC | Regulation of the expression of epidermal keratinocyte proliferation and differentiation by vitamin A analogs. | 1984 | Arch. Dermatol. Res. | pmid:6595966 |
| Weiss VC et al. | Hepatotoxic reactions in a patient treated with etretinate. | 1984 | Arch Dermatol | pmid:6691707 |
| Zachariae H | Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis. | 1984 | Arch Dermatol | pmid:6696467 |
| Lawrence CM et al. | A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. | 1984 | Br. J. Dermatol. | pmid:6696838 |
| Foged EK and Schmidt H | Treatment modalities of psoriatics over a 6-year period (1975-1981). | 1984 | Dermatologica | pmid:6698270 |
| Rosenbaum MM and Roenigk HH | Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate. | 1984 | J. Am. Acad. Dermatol. | pmid:6707259 |
| Marcelo CL et al. | Effect of 1.2 mmol/l calcium, triamcinolone acetonide, and retinoids on low-calcium regulated keratinocyte differentiation. | 1984 | Br. J. Dermatol. | pmid:6204678 |
| DiGiovanna JJ et al. | Etretinate: effect of milk intake on absorption. | 1984 | J. Invest. Dermatol. | pmid:6233379 |
| Schwanitz HJ | [Informing the patient before treatment with etretinate]. | 1984 | Z. Hautkr. | pmid:6719976 |
| El Baze P et al. | Response of epidermal polyamines to orally administered aromatic retinoid RO 10-9359. | 1984 | Arch. Dermatol. Res. | pmid:6721578 |
| DomÃnguez Soto L et al. | [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report]. | 1984 | Med Cutan Ibero Lat Am | pmid:6376979 |
| Melis M | [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)]. | 1984 | Rev Med Chil | pmid:6377426 |
| Pedersen H et al. | Administration of a retinoid as prophylaxis of recurrent non-invasive bladder tumors. | 1984 | Scand. J. Urol. Nephrol. | pmid:6379859 |
| MashkilleÄson AL and MashkilleÄson NA | [Ichthyosiform erythroderma successfully treated with an aromatic retinoid]. | 1984 | Vestn Dermatol Venerol | pmid:6382860 |
| Brambilla L et al. | Unusual cases of Meleda keratoderma treated with aromatic retinoid etretinate. | 1984 | Dermatologica | pmid:6235136 |
| Ashton RE et al. | Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids. | 1984 | J. Invest. Dermatol. | pmid:6586859 |
| Annesley T et al. | Analysis of retinoids by high-performance liquid chromatography using programmed gradient separation. | 1984 | J. Chromatogr. | pmid:6231305 |
| Wong E et al. | The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin. | 1984 | Br J Clin Pharmacol | pmid:6091710 |
| Wereide K | Mutilating palmoplantar keratoderma successfully treated with etretinate. | 1984 | Acta Derm. Venereol. | pmid:6084939 |
| Bauer R et al. | Impaired motility and random migration of vital polymorphonuclears in vitro after therapy with oral aromatic retinoid in psoriasis. | 1984 Jan-Feb | Int. J. Dermatol. | pmid:6724772 |
| Lazzini C et al. | Evaluation of lymphocyte subpopulations with monoclonal antibodies in five psoriatic patients treated with etretinate. | 1984 Jul-Sep | Ric Clin Lab | pmid:6335285 |
| Gruca S and Jakubowicz K | [Treatment of psoriasis with aromatic retinoid derivatives (Tigason) (double-blind method)]. | 1984 May-Jun | Przegl Dermatol | pmid:6395197 |
| Dubertret L et al. | Maintenance treatment of psoriasis by Tigason: a double-blind randomized clinical trial. | 1985 | Br. J. Dermatol. | pmid:3904805 |
| Kanerva LO et al. | Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy. | 1985 | Arch. Dermatol. Res. | pmid:3006608 |
| White SI et al. | Etretinate in pustular psoriasis of palms and soles. | 1985 | Br. J. Dermatol. | pmid:3904810 |
| Wolska H et al. | Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results. | 1985 | Dermatologica | pmid:3908171 |
| Uhlmann A and Bräuninger W | [Therapeutic results with the aromatic retinoid (Tigason) in Sharp syndrome and progressive scleroderma]. | 1985 | Z. Hautkr. | pmid:4013454 |
| Ellis CN et al. | Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes. | 1985 | Arch Dermatol | pmid:4015133 |
| Steiner A et al. | [Pemphigus vegetans (Hallopeau) with eosinophilic spongiosis--successful retinoid therapy]. | 1985 | Hautarzt | pmid:4019190 |
| Shuster S et al. | Retinoids and PUVA in psoriasis. | 1985 | Br. J. Dermatol. | pmid:3970833 |
| Roenigk HH et al. | Serial liver biopsies in psoriatic patients receiving long-term etretinate. | 1985 | Br. J. Dermatol. | pmid:3970836 |
| Massarella J et al. | Etretinate kinetics during chronic dosing in severe psoriasis. | 1985 | Clin. Pharmacol. Ther. | pmid:3979005 |
| Väätäinen N et al. | Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis. | 1985 | J. Am. Acad. Dermatol. | pmid:3980803 |
| Eccles SA et al. | Inhibition of growth and spontaneous metastasis of syngeneic transplantable tumors by an aromatic retinoic acid analogue. 1. Relationship between tumour immunogenicity and responsiveness. | 1985 | Cancer Immunol. Immunother. | pmid:3845848 |
| Levin J and Almeyda J | Erythroderma due to etretinate. | 1985 | Br. J. Dermatol. | pmid:3156618 |
| Köster W and Nasemann T | [Hereditary papulotranslucent acrokeratoderma]. | 1985 | Z. Hautkr. | pmid:3157274 |
| Bennet P et al. | [Development outbreak of ankylosing vertebral hyperostosis induced by a retinoid]. | 1985 | Presse Med | pmid:3157940 |
| Wehrmann W et al. | [The Papillon-Lefevre syndrome (keratosis palmoplantaris with periodontopathy). Treatment with etretinate]. | 1985 | Hautarzt | pmid:3158626 |
| Czernielewski J et al. | Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin. | 1985 | Acta Derm. Venereol. | pmid:2408430 |
| Ruzicka T et al. | Treatment of cutaneous lupus erythematosus with etretinate. | 1985 | Acta Derm. Venereol. | pmid:2413687 |
| Nomura H | [The effect of etretinate on guinea pig keratinocytes]. | 1985 | Nihon Hifuka Gakkai Zasshi | pmid:2416970 |
| Griffiths WA | Retinoids and dyskeratinising disorder. | 1985 | Lancet | pmid:2864568 |
| Grote W et al. | Malformation of fetus conceived 4 months after termination of maternal etretinate treatment. | 1985 | Lancet | pmid:2860474 |
| Burge S and Ryan T | Diffuse hyperostosis associated with etretinate. | 1985 | Lancet | pmid:2862558 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.